Shares of Vertex Pharmaceuticals (VRTX -8.5%) move lower on heavy volume after Pharmasset (VRUS...


Shares of Vertex Pharmaceuticals (VRTX -8.5%) move lower on heavy volume after Pharmasset (VRUS +6.4%) announces further expansion of its Hepatitis C treatment trial, stinging prospects for the company's own line.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs